Search research articles
Contact Us
Filters
Showing results (151-160 of 168) with videos related to
Page
of 17
Sort By:
Transplantation and Cellular Therapy
|
August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes
Betül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.
Leukemia Research
|
November 3, 2017
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs
Allison H Scotch, Heidi Kosiorek, Robyn Scherber, et al.
Transplantation and Cellular Therapy
|
October 3, 2020
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study
Nelli Bejanyan, Meijie Zhang, Khalid Bo-Subait, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2020
Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT
Rohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 12, 2020
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes
Aziz Nazha, Zhen-Huan Hu, Tao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2019
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
Haesook T Kim, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Bone Marrow Transplantation
|
September 29, 2021
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
Antonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri, et al.
Bone Marrow Transplantation
|
April 17, 2021
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation
Mary-Elizabeth Percival, Hai-Lin Wang, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 16, 2019
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation
Ayman Saad, Lawrence Lamb, Tao Wang, et al.
Leukemia Research
|
July 30, 2018
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma
Tomas Radivoyevitch, Robert M Dean, Bronwen E Shaw, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 168) with videos related to
Sort By:
Page
of 17
Transplantation and Cellular Therapy
|
August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes
Betül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.
Leukemia Research
|
November 3, 2017
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs
Allison H Scotch, Heidi Kosiorek, Robyn Scherber, et al.
Transplantation and Cellular Therapy
|
October 3, 2020
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study
Nelli Bejanyan, Meijie Zhang, Khalid Bo-Subait, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2020
Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT
Rohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 12, 2020
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes
Aziz Nazha, Zhen-Huan Hu, Tao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2019
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
Haesook T Kim, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Bone Marrow Transplantation
|
September 29, 2021
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
Antonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri, et al.
Bone Marrow Transplantation
|
April 17, 2021
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation
Mary-Elizabeth Percival, Hai-Lin Wang, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 16, 2019
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation
Ayman Saad, Lawrence Lamb, Tao Wang, et al.
Leukemia Research
|
July 30, 2018
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma
Tomas Radivoyevitch, Robert M Dean, Bronwen E Shaw, et al.
Page
of 17